GeneCapture, Inc.

At GeneCapture, Inc., we've reinvented pathogen detection. We can now identify hundreds of pathogens in an hour for under $20 with a portable reader than can go anywhere. Sample In | Answer Out | Fast #pathology #infectiousdiseases #innovation #breakthroughs

Fungal infections are on the rise worldwide. Species of the genus Candida can cause slow wound healing and invasive Candidiasis which spreads through the bloodstream and around the body, leading to hundreds of thousands of deaths each year. Fungal infections are particularly hard to treat due limited numbers of anti-fungal treatments, and a long time to results for traditional culture testing.   GeneCapture has tested its rapid sample-to-answer antimicrobial susceptibility testing (AST) assay on Candida spp. to three different antifungals with clear results within 5 hours of growth. Data shows a 97% agreement to standard culture methods to-date.    Same day and on-sight fungal pathogen detection and AST will drastically improve treatment outcomes for patients in hospitals and the military alike. 

#jpmorganweek #BiotechShowcase BIO Alabama

Congratulations to GeneCapture’s AST team! We are committed to mitigating Antimicrobial Resistance. After investing several years of R&D to developing our portable Antimicrobial Susceptibility Test (AST), GeneCapture has recently focused on UTIs, and today we report a dataset of 295 bug/drug combinations with a 93.2% agreement to standard culture methods (exceeds FDA agreement requirements). This portable unique rapid test is being developed to run on a fully automated instrument and cartridge system in under two hours, allowing same-day accurate treatment for UTI patients. We are continuing to grow this data with support from advisors, local doctors and laboratories, and our incredible team here at GeneCapture. Megan Roegner Chelsey Ahmadi Scotlynn Lyon Katherine Presz HudsonAlpha Institute for Biotechnology

GeneCapture presented its concept for Pathogen X detection at the ChemBio Science and Technology conference in Fort Lauderdale. #CBDST2024 #DTRA

Protecting global health starts at your local farm. GeneCapture’s Pathogen-X detection system (in development) can be used on that farm to catch an emerging infection and identify its viral family. We are giving farmers an edge on protecting employees and safeguarding our food supply.

Antimicrobial resistant infections are set to kill more than 39 million people in the next 25 years. Knowing that your antibiotic is effective BEFORE you start treatment gives us an edge on antimicrobial resistance and can cut those numbers down. GeneCapture is developing a rapid, point-of-need, antimicrobial susceptibility test that can determine the right antibiotic for a patient within a few hours. https://lnkd.in/e93w7vy7

Pathogenic threats to agriculture, such as H5N1, create a risk to food security that drives the need for expanded diagnostic tools to protect our farms: https://wapo.st/49LSKic

GeneCapture mentioned among groups leading the fight against 'Disease X'...in today's Axios headline: "Hypothetical Disease X drives real spending"   "GeneCapture in Huntsville, Alabama, is developing a rapid test to identify conceptual pathogens like Disease X under a $2.5 million contract with the Department of Defense."   https://lnkd.in/gskvm5Y5

New study shows that screening for invasive fungal diseases - the types taking over hospitals and infecting patients - could help prevent disease spread. Rapid screening tools like rapid, point-of-care diagnostics are essential! https://lnkd.in/gd2e2eJV